Company / Capital Returned to Shareholders per Share
Alaunos Therapeutics, Inc. Capital Returned to Shareholders per Share History
FY2012-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.00
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
-
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2022 to $0.02 in FY2012.
Based on SEC 10-K filings.
0.00 in FY2023 with a 10-year CAGR of -1.6%.
Declined from $0.01 to $0.00 over the past 3 years.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -32.0%
- 5-Year CAGR
- +188.6%
- 10-Year CAGR
- -1.6%
Key checks
Key Insights
- Peak capital returned to shareholders per share was recorded in FY2012.
- Lowest capital returned to shareholders per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | $0.01 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.00 | -99.6% |
| FY2013 | $0.00 | -86.3% |
| FY2012 | $0.02 | +207.4% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026